BridgeMD
New treatment option for Music Intervention
Official title The Effect of a Music Intervention on Postictal Agitation in Electroconvulsive Therapy Patients
ClinicalTrials.gov ID: NCT06817330
What this study is testing
- What it's testing
- This study will investigate the effect of music on postictal agitation when played peri-interventionally for patients undergoing electroconvulsive therapy for severe depression.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients undergoing ECT treatment for depression (including depression as part of bipolar disorder)
- Adult patients (≥18 years)
- Hypnotic agent used is etomidate
- Sufficient understanding of the Dutch language (in judgement of the attending physician or researcher)
- Written informed consent by patient or legal representative
You likely can't join if
- Significant impaired hearing (defined as unable to communicate verbally or listen to music)
- Severe neurological condition (defined as interfering with the ability to process music)
- Patients receiving ECT for treatment of schizophrenic disorders
The study team makes the final eligibility decision.
Where it's taking place
- Rotterdam, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rotterdam, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.